The FDA-approved drug apremilast suppresses alcohol intake: clinical and pre-clinical validation
K. B. Grigsby, R. A. Mangieri, A. J. Roberts, M. J. Lopez, A. Tran, E. J. Firsick, K. G. Townsley, A. Beneze, J. Bess, T. K. Eisenstein, J. J. Meissler, J. M. Light, J. Miller, S. Quello, F. Shadan, , A. R. Ozburn
This study shows that the FDA-approved drug apremilast reduces excessive alcohol drinking in both preclinical models and human studies.
bioRxiv · May 13, 2021 · PreprintAnimal Behavior & Cognition